Literature DB >> 20574169

The non-neoplastic kidney in tumor nephrectomy specimens: what can it show and what is important?

Stephen M Bonsib1, Ying Pei.   

Abstract

Surgical nephrectomy is a procedure that has been performed for nearly 100 years. In the presence of a normal contralateral kidney, such as in a renal transplant donor or child with Wilms tumor, it is a benign procedure without deleterious consequences on the remaining kidney. However, many adults and some children postnephrectomy will develop chronic kidney disease. The non-neoplastic kidney in tumor resections may harbor a large number of developmental and acquired diseases predictive of this outcome or that convey other medically significant information. Examination of the non-neoplastic kidney is a fertile opportunity to identify these unsuspected conditions that may ultimately dictate the subsequent clinical course and influence the medical care provided. This review discusses the consequences of unilateral and partial nephrectomy, and illustrates many conditions that may be encountered in the non-neoplastic cortex with a discussion of their clinical implications.

Entities:  

Mesh:

Year:  2010        PMID: 20574169     DOI: 10.1097/PAP.0b013e3181e3c02d

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  12 in total

1.  Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma.

Authors:  José-Antonio Ortiz-Rey; Carmen Fachal; Laura Juaneda-Magdalena; Mónica Muñoz-Martín; Alfredo Repáraz-Andrade; Susana Teijeira; José-María Lamas-Barreiro; Sheila Almuster-Domínguez; Pilar San Miguel-Fraile; Carolina Gómez-de María
Journal:  Virchows Arch       Date:  2021-01-14       Impact factor: 4.064

Review 2.  The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.

Authors:  Susie L Hu; Anthony Chang; Mark A Perazella; Mark D Okusa; Edgar A Jaimes; Robert H Weiss
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

3.  Initial evidence demonstrating the association between the vascular status in surgically resected renal parenchymal pathology and sexual function.

Authors:  T Sejima; H Iwamoto; T Masago; S Morizane; A Yao; Y Umekita; M Honda; A Takenaka
Journal:  Int J Impot Res       Date:  2014-12-04       Impact factor: 2.896

Review 4.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

5.  Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function.

Authors:  Wassim M Bazzi; Ling Y Chen; Billy H Cordon; Joseph Mashni; Daniel D Sjoberg; Melanie Bernstein; Paul Russo
Journal:  Int Urol Nephrol       Date:  2015-08-12       Impact factor: 2.370

6.  Characterization of mild and severe post-radical nephrectomy renal functional deterioration utilizing histopathological evaluation of non-neoplastic nephrectomized renal parenchyma.

Authors:  Takehiro Sejima; Tetsuya Yumioka; Noriya Yamaguchi; Hideto Iwamoto; Toshihiko Masago; Shuichi Morizane; Masashi Honda; Atsushi Takenaka
Journal:  Int J Clin Oncol       Date:  2015-10-08       Impact factor: 3.402

7.  End stage and chronic kidney disease: associations with renal cancer.

Authors:  Paul Russo
Journal:  Front Oncol       Date:  2012-04-02       Impact factor: 6.244

8.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11

9.  Diabetes and risk of cancer.

Authors:  Samy L Habib; Maciej Rojna
Journal:  ISRN Oncol       Date:  2013-02-07

Review 10.  Urologic Diseases Germane to the Medical Renal Biopsy: Review of a Large Diagnostic Experience in the Context of the Renal Architecture and Its Environs.

Authors:  Stephen M Bonsib
Journal:  Adv Anat Pathol       Date:  2018-09       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.